Barclays
ACH

Barclays’s Accendra Health ACH Stock Holding History

Barclays’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Sell
9,939
-5,339
-35% -$16.6K ﹤0.01% 4443
2026
Q1 		$34.8K Sell
15,278
-102,325
-87% -$236K ﹤0.01% 4434
2025
Q4 		$329K Buy
117,603
+7,536
+7% +$26.9K ﹤0.01% 4082
2025
Q3 		$528K Sell
110,067
-30,500
-22% -$194K ﹤0.01% 3773
2025
Q2 		$1.28M Buy
140,567
+31,628
+29% +$233K ﹤0.01% 3162
2025
Q1 		$984K Sell
108,939
-23,250
-18% -$245K ﹤0.01% 3121
2024
Q4 		$1.73M Sell
132,189
-1,513
-1% -$20.2K ﹤0.01% 2998
2024
Q3 		$2.1M Buy
133,702
+104,305
+355% +$1.58M ﹤0.01% 2811
2024
Q2 		$397K Sell
29,397
-54,590
-65% -$1.12M ﹤0.01% 3187
2024
Q1 		$2.33M Sell
83,987
-32,845
-28% -$729K ﹤0.01% 2447
2023
Q4 		$2.25M Buy
116,832
+74,572
+176% +$1.35M ﹤0.01% 2816
2023
Q3 		$683K Sell
42,260
-2,552
-6% -$45.3K ﹤0.01% 2593
2023
Q2 		$853K Sell
44,812
-6,660
-13% -$119K ﹤0.01% 2407
2023
Q1 		$749K Buy
51,472
+1,005
+2% +$18K ﹤0.01% 2959
2022
Q4 		$986K Buy
50,467
+5,595
+12% +$109K ﹤0.01% 2811
2022
Q3 		$1.08M Buy
44,872
+1,730
+4% +$53.3K ﹤0.01% 2172
2022
Q2 		$1.36M Sell
43,142
-28,815
-40% -$1.04M ﹤0.01% 2126
2022
Q1 		$3.17M Sell
71,957
-31,936
-31% -$1.37M ﹤0.01% 1512
2021
Q4 		$4.52M Buy
103,893
+11,759
+13% +$461K ﹤0.01% 1783
2021
Q3 		$2.88M Buy
92,134
+29,628
+47% +$1.17M ﹤0.01% 2048
2021
Q2 		$2.65M Sell
62,506
-100,965
-62% -$3.93M ﹤0.01% 2004
2021
Q1 		$6.14M Sell
163,471
-15,357
-9% -$480K ﹤0.01% 1361
2020
Q4 		$4.84M Buy
178,828
+9,913
+6% +$255K ﹤0.01% 1540
2020
Q3 		$4.24M Buy
168,915
+12,288
+8% +$179K ﹤0.01% 1504
2020
Q2 		$1.2M Buy
156,627
+16,330
+12% +$120K ﹤0.01% 2598
2020
Q1 		$1.28M Buy
140,297
+16,527
+13% +$99.8K ﹤0.01% 2708
2019
Q4 		$640K Buy
123,770
+54,443
+79% +$350K ﹤0.01% 4082
2019
Q3 		$403K Sell
69,327
-9,896
-12% -$44.4K ﹤0.01% 4416
2019
Q2 		$254K Buy
79,223
+29,604
+60% +$101K ﹤0.01% 4895
2019
Q1 		$204K Buy
49,619
+12,772
+35% +$80.8K ﹤0.01% 4810
2018
Q4 		$233K Sell
36,847
-89,033
-71% -$924K ﹤0.01% 4471
2018
Q3 		$2.08M Buy
125,880
+91,372
+265% +$1.55M ﹤0.01% 2829
2018
Q2 		$577K Sell
34,508
-22,755
-40% -$368K ﹤0.01% 3808
2018
Q1 		$890K Buy
57,263
+20,896
+57% +$373K ﹤0.01% 3353
2017
Q4 		$686K Buy
36,367
+2,268
+7% +$50.3K ﹤0.01% 3499
2017
Q3 		$995K Buy
34,099
+8,867
+35% +$262K ﹤0.01% 3008
2017
Q2 		$811K Buy
25,232
+4,571
+22% +$150K ﹤0.01% 3059
2017
Q1 		$715K Buy
20,661
+215
+1% +$7.68K ﹤0.01% 3052
2016
Q4 		$721K Buy
20,446
+5,958
+41% +$201K ﹤0.01% 3048
2016
Q3 		$503K Sell
14,488
-435
-3% -$15.2K ﹤0.01% 3216
2016
Q2 		$557K Sell
14,923
-844
-5% -$31.7K ﹤0.01% 3122
2016
Q1 		$631K Sell
15,767
-1,484
-9% -$55.3K ﹤0.01% 2938
2015
Q4 		$604K Sell
17,251
-1,656
-9% -$59.9K ﹤0.01% 3064
2015
Q3 		$586K Sell
18,907
-79,359
-81% -$2.7M ﹤0.01% 3218
2015
Q2 		$3.34M Buy
98,266
+35,768
+57% +$1.21M ﹤0.01% 1812
2015
Q1 		$2.06M Buy
62,498
+15,529
+33% +$541K ﹤0.01% 2290
2014
Q4 		$1.64M Buy
46,969
+2,551
+6% +$85.9K ﹤0.01% 2706
2014
Q3 		$1.42M Sell
44,418
-22,386
-34% -$762K ﹤0.01% 2989
2014
Q2 		$2.21M Buy
66,804
+17,175
+35% +$588K ﹤0.01% 2493
2014
Q1 		$1.74M Sell
49,629
-41,679
-46% -$1.47M ﹤0.01% 2686
2013
Q4 		$3.29M Buy
91,308
+23,646
+35% +$868K ﹤0.01% 2169
2013
Q3 		$2.3M Buy
67,662
+33,406
+98% +$1.17M ﹤0.01% 2411
2013
Q2 		$1.16M Buy
+34,256
New +$1.14M ﹤0.01% 3175

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Barclays's ACH Position: Q2 2026 in Review

Barclays reduced its Accendra Health (ACH) stake by 35% in Q2 2026, selling an estimated $16.6K and leaving 9,939 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Barclays first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.14M in Q1 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Barclays held 9,939 shares of Accendra Health worth $34K as of Q2 2026.
  • Barclays sold 5,339 Accendra Health shares in Q2 2026, an estimated $16.6K.
  • Accendra Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4443 holding.
  • Barclays first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Accendra Health position peaked at $6.14M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.